DNO previously required the support of 57.5% Faroe shareholders but now only requires 50%. DNO’s takeover attempts intensified after it lifted its stakes in Faroe. DNO ASA (DNO), a renowned Norwegian oil and gas operator, has reportedly announced that it now requires the support of …
The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …
The biotechnology company GeoVax Labs, Inc. has reportedly announced to have joined hands with the pharmaceutical firm Enesi Pharma to develop needle-free solid-dose vaccine formulations by using its unique Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform along with Enesi’s ImplaVax® device and formulation technology. …
The move will end the halt on introducing new games, offering the gaming industry new opportunities. China, one of the world largest video games market, has recently approved 80 new video game releases licenses through its newly formed media regulatory body, Online Games Ethics Committee, …
Danish wind turbine manufacturer Vestas Wind Systems A/S (Vestas) has reportedly inked a 32 MW agreement for the extension of the Ulassai wind park located in Italy. As per trusted sources, the new contract is based on orders that were announced in all four quarters …
Wichita-based largest first-tier aerostructures manufacturer Spirit AeroSystems has announced that it has reached a long term agreement with Boeing, its largest customer, for a wide range of commercial airplane programs. Financial terms regarding the deal were not yet disclosed by the company. Reportedly, Spirit revealed …
The outcome of the Vectra(R) clinical studies were published in the journal Rheumatology. The adjusted Vectra(R) test is significantly more effective than conventional methods in predicting radiographic progression in individuals suffering from Rheumatoid Arthritis. Myriad Genetics, Inc. (Myriad), a leading American molecular diagnostic firm, has …
DUSA Pharmaceuticals, a wholly-owned Sun Pharma subsidiary, had filed a patent infringement lawsuit against Biofrontera for using its proprietary trade secrets. The lawsuit claimed trade secret misappropriation as well as patent infringement of the firm’s photodynamic therapy patents. Sun Pharmaceutical Industries Ltd. (Sun Pharma), an …
